SLN Overview
Upcoming Projects (SLN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (SLN)
-
A Third Look: Discussing the topline 48-week data from the ongoing phase 2 study of Zerlasiran in patients with high lipoprotein(a)
Ticker: SLN
Executed On: Jul 25, 2024 at 05:45 PM EDT -
A Second Look: Discussing the topline 48-week data from the ongoing phase 2 study of Zerlasiran in patients with high lipoprotein(a)
Ticker: SLN
Executed On: Jul 25, 2024 at 12:30 PM EDT -
Discussing the topline 48-week data from the ongoing phase 2 study of Zerlasiran in patients with high lipoprotein(a)
Ticker: SLN
Executed On: Jul 24, 2024 at 05:30 PM EDT -
A Second Look: Investigating the topline 36-week data from the ongoing phase 2 study of Zerlasiran in patients with high lipoprotein(a).
Ticker: SLN
Executed On: May 06, 2024 at 10:15 AM EDT -
Investigating the topline 36-week data from the ongoing phase 2 study of Zerlasiran in patients with high lipoprotein(a).
Ticker: SLN
Executed On: Apr 03, 2024 at 02:00 PM EDT
Upcoming & Overdue Catalysts (SLN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (SLN)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
